PHARMACEUTICAL COMPOSITION

摘要

The invention relates to a pharmaceutical composition comprising a core containing a HMG- CoA reductase inhibitor, and a film coating surrounding the core. In an embodiment, the core is substantially devoid of any binder, diluent or filler, which allows the composition to be made in relatively small size (eg unit dose of 200 mg) without compromising the dissolution properties of the composition. The invention also provides a method of manufacturing the pharmaceutical composition, and the therapeutic use of the composition.